Insider Transactions in Q1 2022 at Vertex Pharmaceuticals Inc (VRTX)
Insider Transaction List (Q1 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2022
|
Jeffrey M Leiden Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
66,817
+19.03%
|
-
|
|
Feb 01
2022
|
Joy Liu SVP, General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
8,941
+17.74%
|
-
|
|
Feb 01
2022
|
Amit Sachdev EVP Chief Patient & Ext Af Off |
BUY
Grant, award, or other acquisition
|
Direct |
29,638
+16.23%
|
-
|
|
Feb 01
2022
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
SELL
Payment of exercise price or tax liability
|
Direct |
526
-0.93%
|
$127,818
$243.64 P/Share
|
|
Feb 01
2022
|
Bastiano Sanna EVP, Cell & Genetic Therapies |
BUY
Grant, award, or other acquisition
|
Direct |
23,942
+19.36%
|
-
|
|
Feb 01
2022
|
Ourania Tatsis EVP, Chief Reg. & Quality Off. |
BUY
Grant, award, or other acquisition
|
Direct |
27,714
+15.34%
|
-
|
|
Feb 01
2022
|
Charles F Wagner Jr EVP & Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,588
+14.04%
|
-
|
|
Jan 28
2022
|
Margaret G Mcglynn Director |
SELL
Open market or private sale
|
Direct |
5,000
-31.95%
|
$1,210,000
$242.1 P/Share
|
|
Jan 28
2022
|
Margaret G Mcglynn Director |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+45.05%
|
$635,000
$127.54 P/Share
|